Publisher： Bentham Science Publishers
E-ISSN： 1875-5453|17|5|412-429
ISSN： 1389-2002
Source： Current Drug Metabolism, Vol.17, Iss.5, 2016-06, pp. : 412-429
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Introduction: The kynurenine pathway includes several neuroactive compounds, including kynurenic acid, picolinic acid, 3-hydroxykynurenine and quinolinic acid. The enzymatic cascade of the kynurenine pathway is tightly connected with the immune system, and may provide a link between the immune system and neurotransmission.Main Areas Covered: Alterations in this cascade are associated with neurodegenerative, neurocognitive, autoimmune and psychiatric disorders, such as Parkinson’s disease, Huntington’s disease, Alzheimer’s disease, multiple sclerosis, amyotrophic lateral sclerosis, migraine or schizophrenia.Highlights: This review highlights the alterations in this metabolic pathway in the physiological aging process and in different disorders. A survey is also presented of therapeutic possibilities of influencing this metabolic route, which can be achieved through the use of synthetic kynurenic acid analogues, enzyme inhibitors or even nanotechnology.
Related content
Access to resources
Recommend
Ion Channels as Drug Targets in Central Nervous System Disorders
Current Medicinal Chemistry, Vol. 20, Iss. 10, 2013-04 ,pp. :
Melatonin Metabolism in the Central Nervous System
Current Neuropharmacology, Vol. 8, Iss. 3, 2010-09 ,pp. :